Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T04:59:17.524Z Has data issue: false hasContentIssue false

Diagnosis of Prodromal Alzheimer's Disease: Do You Really Want to Know?

Published online by Cambridge University Press:  02 December 2014

Serge Gauthier
Affiliation:
McGill Center for Studies in Aging, Douglas Mental Health University Institute, Montreal, Quebec, Canada
Antoine Leuzy
Affiliation:
McGill Center for Studies in Aging, Douglas Mental Health University Institute, Montreal, Quebec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Porteri, C, Galluzzi, S, Geroldi, C, Frisoni, GB. Diagnosis disclosure of prodromal Alzheimer disease - ethical analysis of two cases. Can J Neurol Sci. 2010; 37: 6775.CrossRefGoogle ScholarPubMed
2. Dubois, B, Feldman, HH, Jacova, C, Dekosky, ST, Barberger-Gateau, P, Cummings, J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revisiting of the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6: 73446.Google Scholar
3. Gauthier, S, Sheltens, P. Can we do better in developing new drugs for Alzheimer’s disease? Alzheimers Dement. 2009; 5: 48991.Google Scholar
4. Green, RC, Roberts, JS, Cupples, LA, Relkin, NR, Whitehouse, PJ, Brown, T, et al. Disclosure of APOE genotype for risk of Alzheimer’s disease. N Engl J Med. 2009; 361: 24554.CrossRefGoogle ScholarPubMed
5. Hogan, DB, Bailey, P, Carswell, A, Clarke, B, Cohen, C, Forbes, D, et al. Management of mild to moderate Alzheimer’s disease and dementia. Alzheimers Dement. 2007; 3: 35584.Google Scholar